Acutus Medical (AFIB) Set to Announce Quarterly Earnings on Thursday

Acutus Medical (NASDAQ:AFIB – Get Rating) is scheduled to post its quarterly earnings results after the market closes on Thursday, March 16th. Analysts expect Acutus Medical to post earnings of ($0.79) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Acutus Medical Stock Performance

NASDAQ:AFIB opened at $0.89 on Tuesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.33 and a current ratio of 5.12. Acutus Medical has a 52-week low of $0.48 and a 52-week high of $2.19. The firm has a market cap of $25.32 million, a price-to-earnings ratio of -0.29 and a beta of 0.95. The business’s fifty day moving average is $1.44 and its 200 day moving average is $1.09.

Institutional Trading of Acutus Medical

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Acutus Medical by 70.1% during the 3rd quarter. Vanguard Group Inc. now owns 1,142,170 shares of the company’s stock valued at $1,005,000 after purchasing an additional 470,719 shares during the period. State Street Corp raised its stake in shares of Acutus Medical by 11.0% during the 1st quarter. State Street Corp now owns 430,865 shares of the company’s stock valued at $599,000 after purchasing an additional 42,578 shares during the period. Renaissance Technologies LLC bought a new stake in shares of Acutus Medical during the 1st quarter valued at $499,000. AQR Capital Management LLC raised its stake in shares of Acutus Medical by 844.0% during the 2nd quarter. AQR Capital Management LLC now owns 174,352 shares of the company’s stock valued at $195,000 after purchasing an additional 155,883 shares during the period. Finally, Mirabella Financial Services LLP bought a new position in Acutus Medical in the 1st quarter worth about $48,000. 36.32% of the stock is currently owned by institutional investors.

About Acutus Medical

(Get Rating)

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.